发明公开
EP1280929A2 VECTORS FOR OCULAR TRANSDUCTION AND USE THEREOF FOR GENETIC THERAPY
审中-公开
FOR AUGENSTRANSDUKTION载体和用途用于治疗遗传
- 专利标题： VECTORS FOR OCULAR TRANSDUCTION AND USE THEREOF FOR GENETIC THERAPY
- 专利标题（中）： FOR AUGENSTRANSDUKTION载体和用途用于治疗遗传
-
申请号： EP01973780.8申请日： 2001-04-30
-
公开(公告)号： EP1280929A2公开(公告)日： 2003-02-05
- 发明人: NEMEROW, Glen R. , VON SEGGERN, Daniel J. , FRIEDLANDER, Marty
- 申请人： Novartis AG , The Scripps Research Institute , Nemerow, Glen R. , Von Seggern, Daniel J. , Friedlander, Marty
- 申请人地址： Lichtstrasse 35 4056 Basel CH
- 专利权人： Novartis AG,The Scripps Research Institute,Nemerow, Glen R.,Von Seggern, Daniel J.,Friedlander, Marty
- 当前专利权人： Novartis AG,The Scripps Research Institute,Nemerow, Glen R.,Von Seggern, Daniel J.,Friedlander, Marty
- 当前专利权人地址： Lichtstrasse 35 4056 Basel CH
- 代理机构： Gros, Florent
- 优先权： US562934 20000501
- 国际公布： WO01083729 20011108
- 主分类号： C12N15/861
- IPC分类号： C12N15/861 ; A61K48/00 ; A61P27/02
摘要：
Adenovirus vector-based gene therapy methods for treating ocular disorders are provided. Adenovirus vectors for therapy of ocular diseases and methods of treatment using the vectors are provided. Compositions, kits, and methods of preparation and use of the vectors for gene therapy are provided.
信息查询
IPC分类:
